White House Faces Deadline to Nominate Permanent CDC Director

As the White House nears a federally mandated deadline to nominate a new director for the Centers for Disease Control and Prevention (CDC), uncertainty remains regarding the administration’s plans. The lack of a permanent leader has raised concerns about the agency’s ability to effectively address public health challenges.

The 210-Day Rule and Current Situation

Federal law, specifically the Vacancies Reform Act, restricts temporary appointments in executive branch positions to a maximum of 210 days. The CDC has been without a permanent director for nearly this length of time. Susan Monarez, PhD, concluded her tenure as CDC director on August 27, 2025. Jim O’Neill initially served as acting director until February 13, 2026, when National Institutes of Health (NIH) Director Jay Bhattacharya, MD, PhD, assumed the role on a temporary basis.

According to Lawrence O. Gostin, JD, professor and founding director of the O’Neill Institute for National and Global Health Law at Georgetown University, the 210-day clock begins when a position becomes vacant and continues regardless of how many individuals serve in an acting capacity. The clock pauses only during Senate consideration of a nominee, restarting if a nominee is rejected, withdrawn, or returned.

With the 210th day of the acting director term approaching on March 25, 2026, the White House has one week to name a permanent director.

Potential Consequences of Delay

The Vacancies Reform Act stipulates that the Comptroller General must report any position exceeding the 210-day window to relevant congressional committees. This could prompt congressional pressure on the administration to submit a nominee. A private lawsuit could potentially nullify actions taken by the acting director if deemed noncompliant with the Vacancies Act. The Vacancies Act: A legal overview

Former CDC leaders have expressed concern that the prolonged absence of a permanent director jeopardizes national health and safety. For much of the past 14 months, individuals without specialized public health expertise have been responsible for key decisions, including approvals from the Advisory Committee on Immunization Practices.

Senate Confirmation Hurdles

The confirmation process for a new CDC director has develop into more complex. Prior to 2025, presidential appointments to the position did not require Senate confirmation. Now, a nominee must gain approval from the full Senate, following review by the Senate Committee on Health, Education, Labor and Pensions, chaired by Senator Bill Cassidy of Louisiana.

Senator Cassidy has publicly criticized the tenure of Robert F. Kennedy Jr. As HHS secretary, particularly regarding his handling of the CDC and vaccine policy. This scrutiny may present a greater challenge for the White House in securing Senate confirmation this year compared to the confirmation of the previous director.

Looking Ahead

The coming week will be critical as the White House decides whether to nominate a new CDC director before the March 25 deadline. The administration’s decision will likely be influenced by the potential for Senate opposition and the ongoing need for stable leadership at the nation’s leading public health agency.

Source: White House approaches deadline to nominate CDC director